- cafead   Oct 01, 2019 at 10:22: AM
via ElevateBio has founded HighPassBio to advance T-cell immunotherapies based on research from the Fred Hutchinson Cancer Research Center. HighPassBio starts life with a phase 1 leukemia cell therapy.
article source
article source